Balyasny Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.65M Buy
24,806
+3,569
+17% +$1.39M 0.01% 700
2025
Q1
$9.24M Buy
21,237
+726
+4% +$316K 0.02% 671
2024
Q4
$7.57M Sell
20,511
-115,037
-85% -$42.4M 0.01% 747
2024
Q3
$70.5M Sell
135,548
-29,856
-18% -$15.5M 0.12% 152
2024
Q2
$89.6M Buy
165,404
+164,604
+20,576% +$89.2M 0.16% 111
2024
Q1
$415K Sell
800
-3,001
-79% -$1.56M ﹤0.01% 1537
2023
Q4
$1.79M Sell
3,801
-87
-2% -$41K ﹤0.01% 1061
2023
Q3
$1.69M Sell
3,888
-189
-5% -$82.3K ﹤0.01% 1030
2023
Q2
$1.81M Buy
+4,077
New +$1.81M ﹤0.01% 1054
2023
Q1
Sell
-72,982
Closed -$37.4M 2317
2022
Q4
$37.4M Buy
+72,982
New +$37.4M 0.1% 198
2022
Q3
Sell
-47,588
Closed -$23M 2441
2022
Q2
$23M Buy
+47,588
New +$23M 0.07% 306
2021
Q4
Sell
-6,844
Closed -$2.55M 2073
2021
Q3
$2.55M Sell
6,844
-18,034
-72% -$6.72M 0.01% 864
2021
Q2
$9.5M Buy
+24,878
New +$9.5M 0.05% 482
2021
Q1
Sell
-40,489
Closed -$13M 1650
2020
Q4
$13M Buy
+40,489
New +$13M 0.07% 330
2020
Q2
Sell
-94,895
Closed -$21.5M 1054
2020
Q1
$21.5M Buy
+94,895
New +$21.5M 0.26% 100
2019
Q3
Sell
-2,804
Closed -$791K 1133
2019
Q2
$791K Sell
2,804
-1,262
-31% -$356K 0.01% 1000
2019
Q1
$1.17M Sell
4,066
-42,928
-91% -$12.3M 0.01% 874
2018
Q4
$12.3M Buy
46,994
+34,712
+283% +$9.12M 0.09% 281
2018
Q3
$3.37M Sell
12,282
-7,063
-37% -$1.94M 0.02% 657
2018
Q2
$4.61M Sell
19,345
-3,341
-15% -$795K 0.02% 567
2018
Q1
$4.98M Buy
22,686
+19,486
+609% +$4.28M 0.02% 593
2017
Q4
$720K Sell
3,200
-25,367
-89% -$5.71M ﹤0.01% 1189
2017
Q3
$5.42M Sell
28,567
-29,904
-51% -$5.68M 0.02% 571
2017
Q2
$11M Buy
58,471
+49,350
+541% +$9.28M 0.05% 437
2017
Q1
$1.51M Sell
9,121
-29,410
-76% -$4.86M 0.01% 827
2016
Q4
$5.54M Buy
+38,531
New +$5.54M 0.03% 535
2016
Q2
Sell
-4,941
Closed -$687K 1042
2016
Q1
$687K Sell
4,941
-496
-9% -$69K ﹤0.01% 621
2015
Q4
$758K Buy
+5,437
New +$758K 0.01% 621